| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.41B | 2.46B | 2.97B | 3.09B | 2.83B | 2.34B |
| Gross Profit | 1.42B | 1.54B | 2.01B | 1.84B | 1.68B | 1.37B |
| EBITDA | 289.00M | 428.00M | 816.00M | 1.02B | 858.00M | 800.20M |
| Net Income | -27.00M | -75.00M | 270.00M | 490.00M | 396.00M | 376.00M |
Balance Sheet | ||||||
| Total Assets | 3.00B | 3.43B | 3.37B | 3.69B | 3.70B | 3.50B |
| Cash, Cash Equivalents and Short-Term Investments | 452.00M | 813.00M | 441.00M | 1.03B | 1.22B | 1.26B |
| Total Debt | 1.55B | 1.92B | 1.57B | 1.49B | 1.40B | 1.36B |
| Total Liabilities | 2.11B | 2.51B | 2.22B | 2.15B | 2.08B | 1.94B |
| Stockholders Equity | 892.00M | 914.00M | 1.15B | 1.53B | 1.61B | 1.56B |
Cash Flow | ||||||
| Free Cash Flow | 464.00M | 278.00M | 294.00M | 571.00M | 534.00M | 473.70M |
| Operating Cash Flow | 539.00M | 429.00M | 506.00M | 750.00M | 699.00M | 591.40M |
| Investing Cash Flow | -100.00M | -127.00M | -231.00M | -153.00M | -167.00M | -93.10M |
| Financing Cash Flow | -332.00M | 48.00M | -865.00M | -815.00M | -578.00M | -156.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £1.07B | 5.13 | 12.32% | ― | 9.64% | 71.55% | |
73 Outperform | £2.78B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
64 Neutral | £620.65M | -23.98 | 4.40% | 3.36% | -2.59% | -46.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £7.17B | 298.74 | 0.69% | 1.18% | 14.13% | -96.12% | |
55 Neutral | £3.91B | -40.23 | -2.99% | ― | -9.44% | -170.53% | |
52 Neutral | £68.41M | -2.45 | 370.62% | ― | -15.13% | 48.56% |